Physician profile
Ryan D Imler
NPI 1215972146
$10,272.20
in general payments reported to CMS, 2019-2025
22 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $223 · 2021: $2,261 · 2022: $2,601 · 2023: $1,120 · 2024: $1,259 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $1,266.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $7,410.30 | 2019-2025 | Precision 1, Precision7, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $604.98 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $342.94 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $297.34 | 2019-2023 | Cequa |
| Bausch & Lomb Americas INC. | $290.84 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $220.47 | 2019-2021 | |
| Biotissue Holdings INC. | $202.10 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $198.46 | 2020-2023 | |
| Maculogix, INC. | $147.24 | 2019-2021 | |
| Lkc Technologies, INC. | $84.74 | 2024 | |
| Sight Sciences, INC. | $70.94 | 2023 | Tearcare System |
| Allergan, INC. | $65.59 | 2021 | |
| Quidel Corporation | $60.36 | 2019 | |
| Kala Pharmaceuticals, INC. | $49.86 | 2021 | |
| Abb Con-Cise Optical Group LLC | $39.13 | 2019-2025 | Contact Lens, Spectacle Lenses |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $39.00 | 2019 | |
| Glaukos Corporation | $31.75 | 2025 | Idosetr |
| Coopervision INC. | $27.28 | 2019-2024 | Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $26.41 | 2025 | Xdemvy |
| Optos, INC. | $24.00 | 2020 | |
| Ivantis, INC | $20.67 | 2021 | |
| Spark Therapeutics, INC. | $17.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Imler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.